Etirinotecan Pegol (NKTR-102) in NSCLC

Clinical trial NCT01773109 · COMPLETED

Trial details

NCT number: NCT01773109
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Non Small Cell Lung Cancer Recurrent Non Small Cell Lung Cancer

Start date: 2013-01-01
Primary completion: 2016-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.